About the compound
GHRH(1-29) analog (D-Ala2 / Gln8 / Ala15 / Leu27) without the maleimide DAC linker. C₁₅₂H₂₅₂N₄₄O₄₂, MW 3367.97 Da.
Mod GRF 1-29 is the 29-residue free peptide YADAIFTNSYRKVLGQLSARKLLQDIMSR with D-Ala2, Gln8, Ala15, and Leu27 substitutions; it lacks the maleimide DAC linker of CJC-1295. Empirical formula C₁₅₂H₂₅₂N₄₄O₄₂; MW 3367.97 Da.
Reconstitution. For in-vitro laboratory handling, dissolve with bacteriostatic water (0.9% benzyl alcohol). Compound is hygroscopic — handle in low-humidity conditions and re-cap immediately.
Stability profile. Lyophilized: stable at room temperature for up to 30 days sealed; long-term storage at -20 °C recommended. Reconstituted material: stable at 2–8 °C for up to 14 days.
Selected primary literature.
- Robberecht P et al., 1986, Eur J Biochem 159(2):399 — structural characterization of the tetrasubstituted GRF(1-29) analog (preclinical in-vitro receptor-binding study).
What remains uncharacterized: concentration-response relationships in any specific in-vitro model system are not implied here. The literature cited above describes molecular-level observations only.
For research use only. Not for human or animal consumption.




